journal article·2026-08Open access

Long-term remodeling of compliance matched tissue engineered vascular grafts is sex specific

Katarina M. Martinet, David R. Maestas, Leon X. Min, Reyhaneh Gholami, Keishi Kohyama, Jacqueline L. Avila, Sang Ho Ye, Kang Kim, William R. Wagner, Jonathan P. Vande Geest

Acta Biomaterialia· Volume 219

Abstract

Compliance matching of tissue engineered vascular grafts (TEVGs) is a promising technique to combat common failure modes seen clinically in small diameter vascular procedures like coronary artery bypass grafting (CABG). However, despite the influence of sex on vascular response to injury, the role of biological sex on the success of TEVG innovations such as compliance matching, namely in long-term remodeling, has been understudied. In this study we fabricated compliance matched TEVGs (CM TEVGs) and hypocompliant TEVGs (Hypo TEVGs) by adjusting the thicknesses of a high polyester urethane urea (PEUU) containing layer (80:20 PEUU:Gelatin) and a low PEUU containing layer (20:80 PEUU:Gelatin). All grafts were implanted into the abdominal aorta of both male and female Sprague Dawley rats (n = 4) as interposition grafts for 6 months and monitored using in vivo ultrasound. Upon explant, key outcomes of long-term remodeling were assessed via immunohistochemistry, multiphoton imaging, and qRT-PCR. CM TEVGs were confirmed to be compliance matched to native aorta both in vitro and in vivo upon implant. After remodeling, CM TEVGs had increased degradation and decreased calcification compared to Hypo TEVGs. CM TEVGs had increased mature VSMC genes (Acta2, Myh11, Cnn1) in males and decreased macrophage presence (CD68) in females. Independent of graft type, females had increased intimal thickening, decreased luminal presence of mature VSMCs, and increased fibrillar collagen deposition compared to males in both CM and Hypo TEVGs. Our results suggest that long-term remodeling outcomes in response to compliance matching are dependent on biological sex at both the tissue and cellular level.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Infectious Aortic and Vascular Conditions · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (80)

Show source-provided references
1. Heart disease and stroke statistics—2022 update: A report from the American heart association10.1161/CIR.0000000000001052 ↗
2. Global burden of cardiovascular diseases and risk factors, 1990–2019 update from the GBD 2019 study10.1016/j.jacc.2020.11.010 ↗
3. Coronary artery bypass with multiarterial grafting versus percutaneous coronary intervention
4. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery results from a department of veterans affairs cooperative study10.1016/j.jacc.2004.08.064 ↗
5. Saphenous vein graft failure after coronary artery bypass surgery10.1161/CIRCULATIONAHA.113.008193 ↗
6. Current status of prosthetic bypass grafts: A review10.1002/jbm.b.30247 ↗
7. Emerging regulators of vascular smooth muscle cell migration10.1007/s10974-019-09531-z ↗
8. Regulation of vascular smooth muscle cell differentiation10.1016/j.jvs.2007.03.001 ↗
9. Mature vascular smooth muscle cells, but not endothelial cells, serve as the major cellular source of intimal hyperplasia in vein grafts10.1161/ATVBAHA.120.314465 ↗
10. Mechanisms, consequences, and prevention of coronary graft failure10.1161/CIRCULATIONAHA.117.027597 ↗
11. Electrospun vascular grafts with improved compliance matching to native vessels10.1002/jbm.b.33201 ↗
12. A compliant and biomimetic three-layered vascular graft for small blood vessels
13. Elucidating the role of graft compliance mismatch on intimal hyperplasia using an ex vivo organ culture model10.1016/j.actbio.2019.03.025 ↗
14. Tissue engineered vascular grafts are resistant to the formation of dystrophic calcification10.1038/s41467-024-46431-4 ↗
15. In-vivo assessment of a tissue engineered vascular graft computationally optimized for target vessel compliance10.1016/j.actbio.2020.12.058 ↗
16. Computationally optimizing the compliance of a biopolymer based tissue engineered vascular graft10.1115/1.4032060 ↗
17. Computationally optimizing the compliance of multilayered biomimetic tissue engineered vascular grafts10.1115/1.4042902 ↗
18. Sex differences in cardiovascular medicine: Bilateral internal mammary artery CABG10.1016/j.ijcard.2019.03.011 ↗
19. Sex differences in outcomes after coronary artery bypass grafting10.1053/j.jvca.2020.04.030 ↗
20. Mechanistic pathways of sex differences in cardiovascular disease10.1152/physrev.00021.2015 ↗
21. The expanding complexity of estrogen receptor signaling in the cardiovascular system10.1161/CIRCRESAHA.115.305376 ↗
22. Toward sex-specific biomaterials innovation: A perspective10.1021/acsbiomaterials.5c00342 ↗
23. Dynamically stiffening biomaterials reveal age- and sex-specific differences in pulmonary arterial adventitial fibroblast activation10.1016/j.mbplus.2024.100145 ↗
24. Sex-specific response to combinations of shear stress and substrate stiffness by endothelial cells in vitro
25. Biodegradable polyurethane scaffolds in regenerative medicine: Clinical translation review10.1002/jbm.a.37394 ↗
26. Nonthrombogenic, biodegradable elastomeric polyurethanes with variable sulfobetaine content10.1021/am506998s ↗
27. In vivo assessment of a tissue-engineered vascular graft combining a biodegradable elastomeric scaffold and muscle-derived stem cells in a rat model10.1089/ten.tea.2009.0427 ↗
28. Pulse pressure, aortic reactivity, and endothelium dysfunction in old hypertensive rats10.1161/01.HYP.37.2.313 ↗
29. Pulse pressure and arterial stiffness in rats: comparison with humans10.1152/ajpheart.00513.2003 ↗
30. Cazzaniga · 2026
31. Medical image computing and computer-assisted intervention — MICCAI’98, first international conference Cambridge, MA, USA, october 11–13, 1998 proceedings
32. Analysis of relative gene expression data using real-time quantitative PCR and the 2-C T method10.1006/meth.2001.1262 ↗
33. Phenotypic modulation of smooth muscle cells by chemical and mechanical cues of electrospun tecophilic/gelatin nanofibers10.1021/am405673h ↗
34. Stiffness of aligned fibers regulates the phenotypic expression of vascular smooth muscle cells10.1021/acsami.9b00293 ↗
35. The role of mechanotransduction on vascular smooth muscle myocytes cytoskeleton and contractile function10.1002/ar.22983 ↗
36. Phenotypical plasticity of vascular smooth muscle CellsEffect of in vitro and in vivo shear stress for tissue engineering of blood vessels10.1089/ten.2006.0424 ↗
37. Sex differences in the genetic and molecular mechanisms of coronary artery disease10.1016/j.atherosclerosis.2023.117279 ↗
38. 17B-estradiol inhibits proliferation and oxidative stress in vascular smooth muscle cells by upregulating BHLHE40 expression10.3389/fcvm.2021.768662 ↗
39. Rapid estrogen receptor signaling mediates estrogen-induced inhibition of vascular smooth muscle cell proliferation10.1161/ATVBAHA.112.300752 ↗
40. Influences of sex and estrogen in arterial and valvular calcification10.3389/fendo.2019.00622 ↗
41. The role of estrogen receptor and b in regulating vascular smooth muscle cell proliferation is based on Sex110.1016/j.jss.2011.09.021 ↗
42. The role of endothelial cells and their progenitors in intimal hyperplasia10.1177/1753944710362903 ↗
43. Differences in transforming growth factor-B1/BMP7 signaling and venous fibrosis contribute to female sex differences in arteriovenous fistulas
44. Altered hemodynamics during arteriovenous fistula remodeling leads to reduced fistula patency in female mice
45. Long-term evaluation of vascular grafts with circumferentially aligned microfibers in a rat abdominal aorta replacement model10.1002/jbm.b.34076 ↗
46. Well-organized neointima of large-pore poly(l-lactic acid) vascular graft coated with poly(l-lactic-co-e-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(l-lactic acid) graft in a mouse aortic implantation model10.1016/j.atherosclerosis.2014.09.030 ↗
47. Vascular calcification: Mechanisms of vascular smooth muscle cell calcification10.1016/j.tcm.2014.10.021 ↗
48. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness10.1093/cvr/cvy010 ↗
49. Regulatory role of sex hormones in cardiovascular calcification10.3390/ijms22094620 ↗
50. Fast-degrading bioresorbable arterial vascular graft with high cellular infiltration inhibits calcification of the graft10.1016/j.jvs.2016.05.096 ↗
51. Degradation of polyurethanesfor cardiovascular applications
52. Acute elution of TGFB2 affects the smooth muscle cells in a compliance-matched vascular graft10.1089/ten.tea.2021.0161 ↗
53. Mechanisms and consequences of sex differences in immune responses10.1038/s41581-023-00787-w ↗
54. Estrogen receptor functions and pathways at the vascular immune interface10.3390/ijms22084254 ↗
55. 17B-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor signaling in macrophages in vivo10.4049/jimmunol.0902383 ↗
56. Estrogen receptor-alpha promotes alternative macrophage activation during cutaneous repair10.1038/jid.2014.175 ↗
57. The importance of sex-based comparisons in preclinical nanomedicine and regenerative chronic wound therapies10.1021/acsbiomaterials.5c00996 ↗
58. Substrate elasticity regulates the behavior of human monocyte-derived macrophages10.1007/s00249-015-1096-8 ↗
59. Reduced substrate stiffness promotes M2-like macrophage activation and enhances peroxisome proliferator-activated receptor expression10.1016/j.yexcr.2018.04.005 ↗
60. Nerve regeneration and elastin formation within poly(glycerol sebacate)-based synthetic arterial grafts one-year post-implantation in a rat model10.1016/j.biomaterials.2013.09.081 ↗
61. Human umbilical endothelial cells (HUVECs) have a sex: characterisation of the phenotype of male and female cells10.1186/s13293-014-0018-2 ↗
62. Sex differences influencing micro- and macrovascular endothelial phenotype in vitro10.1113/JP276048 ↗
63. Does cellular sex matter? Dimorphic transcriptional differences between female and male endothelial cells10.1016/j.atherosclerosis.2015.02.018 ↗
64. Sex-specific and hormone-related differences in vascular remodelling in atherosclerosis10.1111/eci.13885 ↗
65. Long term evaluation of nanofibrous, bioabsorbable polycarbonate urethane grafts for small diameter vessel replacement in rodents10.1016/j.ejvs.2019.11.004 ↗
66. Tailoring the degradation kinetics of poly(ester carbonate urethane)urea thermoplastic elastomers for tissue engineering scaffolds10.1016/j.biomaterials.2010.02.005 ↗
67. In vitro degradation and in vivo biocompatibility study of a new linear poly(urethane urea)10.1002/jbm.b.30986 ↗
68. Substantial expression of mature elastin in arterial constructs10.1073/pnas.1017834108 ↗
69. Cell-free vascular grafts that grow with the host10.1002/adfm.202005769 ↗
70. Regenerative and durable small-diameter graft as an arterial conduit10.1073/pnas.1905966116 ↗
71. Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model10.1016/j.biomaterials.2011.09.024 ↗
72. In vivo performance of a phospholipid-coated bioerodable elastomeric graft for small-diameter vascular applications10.1002/jbm.a.32997 ↗
73. Optimization of electrospun poly(caprolactone) fiber diameter for vascular scaffolds to maximize smooth muscle cell infiltration and phenotype modulation10.3390/polym11040643 ↗
74. Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction10.1007/s10439-013-0933-0 ↗
75. Prosthetic vascular grafts engineered to combat calcification: Progress and future directions10.1002/bit.28316 ↗
76. Hemodynamics and wall mechanics of vascular graft failure10.1161/ATVBAHA.123.318239 ↗
77. Animal models for vascular tissue-engineering10.1016/j.copbio.2013.05.005 ↗
78. Different degradation rates of nanofiber vascular grafts in small and large animal models10.1002/term.2977 ↗
79. The progress of advanced ultrasonography in assessing aortic stiffness and the application discrepancy between humans and rodents10.3390/diagnostics11030454 ↗
80. Estrogen effects on vascular inflammation are age dependent10.1161/ATVBAHA.114.303629 ↗